Adam Crisp

1.8k total citations · 1 hit paper
19 papers, 1.2k citations indexed

About

Adam Crisp is a scholar working on Statistics and Probability, Epidemiology and Psychiatry and Mental health. According to data from OpenAlex, Adam Crisp has authored 19 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Statistics and Probability, 6 papers in Epidemiology and 5 papers in Psychiatry and Mental health. Recurrent topics in Adam Crisp's work include Cytomegalovirus and herpesvirus research (5 papers), Migraine and Headache Studies (4 papers) and Statistical Methods in Clinical Trials (4 papers). Adam Crisp is often cited by papers focused on Cytomegalovirus and herpesvirus research (5 papers), Migraine and Headache Studies (4 papers) and Statistical Methods in Clinical Trials (4 papers). Adam Crisp collaborates with scholars based in United Kingdom, United States and Germany. Adam Crisp's co-authors include Douglas J. Norman, David C. Lowance, Patrick J. Brennan, Michael R. Keating, Christophe Legendre, R. Méndez, Josef Kovařík, Arnold S. Monto, James M. Hinson and Michael J. Elliott and has published in prestigious journals such as New England Journal of Medicine, JAMA and Blood.

In The Last Decade

Adam Crisp

18 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal Transplantation

1999 536 citations David C. Lowance, Christophe Legendre et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Adam Crisp United Kingdom	10	886	339	231	191	164	19	1.2k
David C. Lowance United States	6	508 0.6×	118 0.3×	130 0.6×	133 0.7×	33 0.2×	6	717
John E. Payne Australia	14	312 0.4×	31 0.1×	63 0.3×	280 1.5×	72 0.4×	50	832
Mukut Minz India	19	287 0.3×	60 0.2×	213 0.9×	112 0.6×	17 0.1×	87	1.1k
José Medina‐Pestana Brazil	15	328 0.4×	114 0.3×	259 1.1×	113 0.6×	16 0.1×	124	998
Jennifer Trofe‐Clark United States	18	294 0.3×	125 0.4×	252 1.1×	280 1.5×	18 0.1×	48	1.3k
Lorenz Grigull Germany	16	207 0.2×	17 0.1×	144 0.6×	130 0.7×	25 0.2×	56	745
Anna Bjerre Norway	21	265 0.3×	27 0.1×	73 0.3×	42 0.2×	18 0.1×	60	1.1k
Jean-Pierre Venetz Switzerland	14	227 0.3×	45 0.1×	110 0.5×	107 0.6×	14 0.1×	36	704
Enric Pedrol Spain	24	484 0.5×	25 0.1×	907 3.9×	81 0.4×	48 0.3×	91	1.8k
Jean‐Philippe Chave Switzerland	16	499 0.6×	11 0.0×	864 3.7×	48 0.3×	33 0.2×	21	1.3k

Countries citing papers authored by Adam Crisp

Since Specialization

Citations

This map shows the geographic impact of Adam Crisp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Crisp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Crisp more than expected).

Fields of papers citing papers by Adam Crisp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Crisp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Crisp. The network helps show where Adam Crisp may publish in the future.

Co-authorship network of co-authors of Adam Crisp

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Crisp. A scholar is included among the top collaborators of Adam Crisp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Crisp. Adam Crisp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Crisp, Adam, et al.. (2023). Microbusinesses’ challenges and perceptions in using social media during the COVID-19 crisis. International Journal of Technology Management and Sustainable Development. 22(1). 79–98. 1 indexed citations

Crisp, Adam, Sam Miller, Douglas Thompson, & Nicky Best. (2018). Practical experiences of adopting assurance as a quantitative framework to support decision making in drug development. Pharmaceutical Statistics. 17(4). 317–328. 17 indexed citations

Gallo, Paul, Adam Crisp, Lisa M. LaVange, et al.. (2018). The changing landscape of data monitoring committees—Perspectives from regulators, members, and sponsors. Biometrical Journal. 61(5). 1232–1241. 4 indexed citations

O’Donoghue, Michelle L., Ruchira Glaser, Philip E. Aylward, et al.. (2015). Rationale and design of the LosmApimod To Inhibit p38 MAP kinase as a TherapeUtic target and moDify outcomes after an acute coronary syndromE trial. American Heart Journal. 169(5). 622–630.e6. 23 indexed citations

Crisp, Adam. (2015). Blinding in pharmaceutical clinical trials: An overview of points to consider. Contemporary Clinical Trials. 43. 155–163. 8 indexed citations

Crisp, Adam & Paula Curtis. (2007). Sample size estimation for non‐inferiority trials of time‐to‐event data. Pharmaceutical Statistics. 7(4). 236–244. 11 indexed citations

Egan, Jim, et al.. (2002). Valacyclovir prevention of cytomegalovirus reactivation after heart transplantation: a randomized trial. The Journal of Heart and Lung Transplantation. 21(4). 460–466. 36 indexed citations

Ljungman, Per, Rafael de la Cámara, Nöel Milpied, et al.. (2002). Randomized study of valacyclovir as prophylaxis against cytomegalovirus reactivation in recipients of allogeneic bone marrow transplants. Blood. 99(8). 3050–3056. 136 indexed citations

Göbel, Hartmut, et al.. (2000). Comparison of naratriptan and sumatriptan in recurrence-prone migraine patients. Clinical Therapeutics. 22(8). 981–989. 21 indexed citations

10.

Gnecchi‐Ruscone, Tomaso, P. Pierre, N.J. Legg, et al.. (2000). Effect of naratriptan on myocardial blood flow and coronary vasodilator reserve in migraineurs. Neurology. 55(1). 95–99. 9 indexed citations

11.

Cady, Roger, Fred D. Sheftell, Richard B. Lipton, et al.. (2000). Effect of early intervention with sumatriptan on migraine pain: Retrospective analyses of data from three clinical trials. Clinical Therapeutics. 22(9). 1035–1048. 182 indexed citations

12.

Monto, Arnold S., D. Paul Robinson, M. Louise Herlocher, et al.. (1999). Zanamivir in the Prevention of Influenza Among Healthy Adults. JAMA. 282(1). 31–31. 233 indexed citations

13.

Lowance, David C., Christophe Legendre, Josef Kovařík, et al.. (1999). Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal Transplantation. New England Journal of Medicine. 340(19). 1462–1470. 536 indexed citations breakdown →

14.

Gnecchi‐Ruscone, Tomaso, Roberto Lorenzoni, N.J. Legg, et al.. (1998). Effects of Ergotamine on Myocardial Blood Flow in Migraineurs Without Evidence of Atherosclerotic Coronary Artery Disease 11The study was partly sponsored by Glaxo-Wellcome R&D, Greenford, United Kingdom.. The American Journal of Cardiology. 81(9). 1165–1168. 5 indexed citations

15.

Norman, Douglas J., et al.. (1998). Valaciclovir Reduces the Incidence of Cytomegalovirus Disease and Acute Graft Rejection in CMV-Seronegative Recipients of a Seropositive Cadaveric Renal Allograft. Transplantation. 65(Supplement). 94–94. 7 indexed citations

16.

Neumayer, H. H., et al.. (1998). Valaciclovir Reduces the Incidence of Cytomegalovirus Disease and Acute Graft Rejection in CMV-Seronegative Recipients of a Seropositive Cadaveric Renal Allograft. Transplantation. 65(12). S18–S18. 5 indexed citations

17.

Crisp, Adam & J. Burridge. (1994). A Note on Nonregular Likelihood Functions in Heteroscedastic Regression Models. Biometrika. 81(3). 585–585. 1 indexed citations

18.

Crisp, Adam & J. Burridge. (1994). A note on nonregular likelihood functions in heteroscedastic regression models. Biometrika. 81(3). 585–587. 10 indexed citations

19.

Crisp, Adam & J. Burridge. (1993). A Note on the Uniqueness of M-Estimators in Robust Regression. Canadian Journal of Statistics. 21(2). 205–205. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact